Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 29, 2019 Filed Jul 30, 2019 20:31 UTC |
Evoli LisaChief Human Resources Officer
|
SaleCommon Stock | 2,380 | $63.00 | $149,940.00 |
DisclosureSEC source: 0001209191-19-043665 · doc4.xml · nonDerivative · entry 1 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,588 Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 20:10 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
SaleCommon Stock | 5,000 | $60.00 | $300,000.00 |
DisclosureSEC source: 0001209191-19-043327 · doc4.xml · nonDerivative · entry 1 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,392 F1 · kind: The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 20:14 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 5,052 | $0.00 Strike: $32.59 | $0.00 |
DisclosureSEC source: 0001209191-19-043330 · doc4.xml · derivative · entry 7 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,736 Underlying: Common Stock · 5,052 shares Expires 2024-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F4 · derivative.exercise_date: 25% of the stock options vest every first, second, third and fourth anniversaries of the grant date of 3/14/2016. F5 · balance_after: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 20:14 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,698 | $0.00 Strike: $26.87 | $0.00 |
DisclosureSEC source: 0001209191-19-043330 · doc4.xml · derivative · entry 6 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,566 Underlying: Common Stock · 4,698 shares Expires 2023-03-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2 · derivative.exercise_date: 25% of the shares of stock options will vest each of the first, second, third and fourth anniversaries of the grant date of 03/23/2015. F3 · balance_after: This stock option was previously reported as covering 2,710 shares of common stock at an exercise price of $62.10 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 20:14 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
SaleCommon Stock | 5,052 | $63.00 | $318,276.00 |
DisclosureSEC source: 0001209191-19-043330 · doc4.xml · nonDerivative · entry 5 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,272 F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 20:14 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Exercise / conversionCommon Stock | 5,052 | $32.59 | $164,619.42 |
DisclosureSEC source: 0001209191-19-043330 · doc4.xml · nonDerivative · entry 4 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 20:14 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
SaleCommon Stock | 4,698 | $63.00 | $295,974.00 |
DisclosureSEC source: 0001209191-19-043330 · doc4.xml · nonDerivative · entry 3 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,272 F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 20:14 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Exercise / conversionCommon Stock | 4,698 | $26.87 | $126,211.77 |
DisclosureSEC source: 0001209191-19-043330 · doc4.xml · nonDerivative · entry 2 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 20:14 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
SaleCommon Stock | 11,234 | $63.14 | $709,258.59 |
DisclosureSEC source: 0001209191-19-043330 · doc4.xml · nonDerivative · entry 1 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,272 F1 · kind: The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F1 · price: The transactions reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| July 24, 2019 Filed Jul 26, 2019 20:12 UTC |
Coleman GlennCVP, CHIEF OPERATING OFFICER
|
SaleCommon Stock | 3,500 | $57.50 | $201,250.00 |
DisclosureSEC source: 0001209191-19-043328 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · CVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,194 F1 · kind: The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 18:05 UTC |
Anderson Carrie LCVP, Chief Financial Officer
|
GrantCommon Stock | 30,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-040845 · doc4.xml · nonDerivative · entry 1 Anderson Carrie L · CIK 0001706446 · CVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,675 Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 18:06 UTC |
Coleman GlennCVP, CHIEF OPERATING OFFICER
|
GrantCommon Stock | 13,534 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-040848 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · CVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,694 Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:14 UTC |
Coleman GlennCVP, CHIEF OPERATING OFFICER
|
SaleCommon Stock | 3,650 | $55.00 | $200,750.00 |
DisclosureSEC source: 0001209191-19-040218 · doc4.xml · nonDerivative · entry 1 Coleman Glenn · CIK 0001434369 · CVP, CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,160 F1 · kind: The transaction reported in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Read SEC document |
| May 17, 2019 Filed May 20, 2019 20:24 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 34 | $49.43 | $1,680.62 |
DisclosureSEC source: 0001209191-19-031383 · doc4.xml · nonDerivative · entry 4 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,935 Read SEC document |
| May 17, 2019 Filed May 20, 2019 20:24 UTC |
BRADLEY KEITHDirector
|
Tax withholdingCommon Stock | 7 | $49.43 | $346.01 |
DisclosureSEC source: 0001209191-19-031383 · doc4.xml · nonDerivative · entry 3 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,969 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:21 UTC |
Ballintyn Rhonda GermanyDirector
|
GrantCommon Stock | 747 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031374 · doc4.xml · nonDerivative · entry 2 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,197 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:21 UTC |
Ballintyn Rhonda GermanyDirector
|
GrantCommon Stock | 3,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031374 · doc4.xml · nonDerivative · entry 1 Ballintyn Rhonda Germany · CIK 0001693474 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,450 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:24 UTC |
BRADLEY KEITHDirector
|
GrantCommon Stock | 747 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031383 · doc4.xml · nonDerivative · entry 2 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,976 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:24 UTC |
BRADLEY KEITHDirector
|
GrantCommon Stock | 3,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031383 · doc4.xml · nonDerivative · entry 1 BRADLEY KEITH · CIK 0001188650 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,229 Read SEC document |
| May 16, 2019 Filed May 20, 2019 22:34 UTC |
MOREL DONALD E JRDirector
|
GrantCommon Stock | 3,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031528 · doc4.xml · nonDerivative · entry 1 MOREL DONALD E JR · CIK 0001213306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,682 Read SEC document |
| May 16, 2019 Filed May 20, 2019 22:21 UTC |
ESSIG STUARTDirector
|
GrantCommon Stock | 4,681 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031516 · doc4.xml · nonDerivative · entry 1 ESSIG STUART · CIK 0001187574 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,788,577 F1 · balance_after: On September 13, 2018, in accordance with the provisions of his Grantor Retained Annuity Trust (the "GRAT"), 179,347 shares were distributed from the GRAT to the reporting person. On October 12, 2018, in accordance with the provisions of his Grantor Retained Annuity Trust (the "GRAT"), 185,630 shares were distributed from the GRAT to the reporting person. Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:44 UTC |
SCHADE CHRISTIAN SDirector
|
GrantCommon Stock | 747 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031429 · doc4.xml · nonDerivative · entry 2 SCHADE CHRISTIAN S · CIK 0001214496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,165 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:44 UTC |
SCHADE CHRISTIAN SDirector
|
GrantCommon Stock | 3,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031429 · doc4.xml · nonDerivative · entry 1 SCHADE CHRISTIAN S · CIK 0001214496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,418 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:31 UTC |
Murphy Raymond G.Director
|
GrantCommon Stock | 3,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031395 · doc4.xml · nonDerivative · entry 1 Murphy Raymond G. · CIK 0001461806 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,162 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:27 UTC |
HOWELL LLOYD JRDirector
|
GrantCommon Stock | 747 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031391 · doc4.xml · nonDerivative · entry 2 HOWELL LLOYD JR · CIK 0001505488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,142 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:27 UTC |
HOWELL LLOYD JRDirector
|
GrantCommon Stock | 3,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031391 · doc4.xml · nonDerivative · entry 1 HOWELL LLOYD JR · CIK 0001505488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,395 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:25 UTC |
HILL BARBARA BDirector
|
GrantCommon Stock | 1,494 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031386 · doc4.xml · nonDerivative · entry 2 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,660 Read SEC document |
| May 16, 2019 Filed May 20, 2019 20:25 UTC |
HILL BARBARA BDirector
|
GrantCommon Stock | 3,785 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031386 · doc4.xml · nonDerivative · entry 1 HILL BARBARA B · CIK 0001235676 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,166 Read SEC document |
| May 10, 2019 Filed May 14, 2019 20:19 UTC |
SCHADE CHRISTIAN SDirector
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 15,658 | $0.00 Strike: $21.97 | $0.00 |
DisclosureSEC source: 0001209191-19-029618 · doc4.xml · derivative · entry 3 SCHADE CHRISTIAN S · CIK 0001214496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,658 shares Expires 2019-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This option was previously reported as covering 7,500 shares at an exercise price of $50.78 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $43.93 per share. F3 · derivative.exercise_price: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. F2 · shares: This option was previously reported as covering 7,500 shares at an exercise price of $50.78 per share, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of SeaSpine Holdings Corporation on July 1, 2015 to 7,829 shares of common stock at an exercise price of $43.93 per share. F3 · shares: In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016. F4 · derivative.exercise_date: 25% of the stock options vested every quarter from the grant date of 5/19/2011 Read SEC document |
| May 10, 2019 Filed May 14, 2019 20:19 UTC |
SCHADE CHRISTIAN SDirector
|
SaleCommon Stock | 15,658 | $51.56 | $807,328.05 |
DisclosureSEC source: 0001209191-19-029618 · doc4.xml · nonDerivative · entry 2 SCHADE CHRISTIAN S · CIK 0001214496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,633 F1 · price: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $51.50 to $52.50. Read SEC document |
| May 10, 2019 Filed May 14, 2019 20:19 UTC |
SCHADE CHRISTIAN SDirector
|
Exercise / conversionCommon Stock | 15,658 | $21.97 | $343,927.97 |
DisclosureSEC source: 0001209191-19-029618 · doc4.xml · nonDerivative · entry 1 SCHADE CHRISTIAN S · CIK 0001214496 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,291 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 22:54 UTC |
Evoli LisaChief Human Resources Officer
|
SaleCommon Stock | 1,291 | $55.90 | $72,166.90 |
DisclosureSEC source: 0001209191-19-020108 · doc4.xml · nonDerivative · entry 1 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,968 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:29 UTC |
VINHAIS JOSEPHCorp VP, Global Qlty Assurance
|
Tax withholdingCommon Stock | 72 | $56.14 | $4,042.08 |
DisclosureSEC source: 0001209191-19-019778 · doc4.xml · nonDerivative · entry 7 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,141 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:29 UTC |
VINHAIS JOSEPHCorp VP, Global Qlty Assurance
|
Tax withholdingCommon Stock | 267 | $56.14 | $14,989.38 |
DisclosureSEC source: 0001209191-19-019778 · doc4.xml · nonDerivative · entry 6 VINHAIS JOSEPH · CIK 0001563599 · Corp VP, Global Qlty Assurance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,213 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:27 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Tax withholdingCommon Stock | 110 | $56.14 | $6,175.40 |
DisclosureSEC source: 0001209191-19-019776 · doc4.xml · nonDerivative · entry 7 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,392 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:27 UTC |
REUVERS DANIEL L.CVP,PRES - CODMAN SPC SURGICAL
|
Tax withholdingCommon Stock | 411 | $56.14 | $23,073.54 |
DisclosureSEC source: 0001209191-19-019776 · doc4.xml · nonDerivative · entry 6 REUVERS DANIEL L. · CIK 0001563602 · CVP,PRES - CODMAN SPC SURGICAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,502 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:25 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 120 | $56.14 | $6,736.80 |
DisclosureSEC source: 0001209191-19-019772 · doc4.xml · nonDerivative · entry 6 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,257 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:25 UTC |
Mosebrook JeffreyPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 180 | $56.14 | $10,105.20 |
DisclosureSEC source: 0001209191-19-019772 · doc4.xml · nonDerivative · entry 5 Mosebrook Jeffrey · CIK 0001719686 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,337 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:25 UTC |
OGRADY JUDITHCorpVP,Global Reg.Affairs
|
Tax withholdingCommon Stock | 66 | $56.14 | $3,705.24 |
DisclosureSEC source: 0001209191-19-019774 · doc4.xml · nonDerivative · entry 7 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,838 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:25 UTC |
OGRADY JUDITHCorpVP,Global Reg.Affairs
|
Tax withholdingCommon Stock | 247 | $56.14 | $13,866.58 |
DisclosureSEC source: 0001209191-19-019774 · doc4.xml · nonDerivative · entry 6 OGRADY JUDITH · CIK 0001187573 · CorpVP,Global Reg.Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,904 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:23 UTC |
MOORADIAN JOHNCorp VP, Global Ops & Supp Chn
|
Tax withholdingCommon Stock | 98 | $56.14 | $5,501.72 |
DisclosureSEC source: 0001209191-19-019771 · doc4.xml · nonDerivative · entry 8 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,410 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:23 UTC |
MOORADIAN JOHNCorp VP, Global Ops & Supp Chn
|
Tax withholdingCommon Stock | 366 | $56.14 | $20,547.24 |
DisclosureSEC source: 0001209191-19-019771 · doc4.xml · nonDerivative · entry 7 MOORADIAN JOHN · CIK 0001563593 · Corp VP, Global Ops & Supp Chn 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,508 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:20 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Tax withholdingCommon Stock | 309 | $56.14 | $17,347.26 |
DisclosureSEC source: 0001209191-19-019757 · doc4.xml · nonDerivative · entry 7 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,506 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:20 UTC |
DAVIS ROBERT T. JR.CVP,PRES-ORTHO & TISSUE TECH
|
Tax withholdingCommon Stock | 1,155 | $56.14 | $64,841.70 |
DisclosureSEC source: 0001209191-19-019757 · doc4.xml · nonDerivative · entry 6 DAVIS ROBERT T. JR. · CIK 0001563606 · CVP,PRES-ORTHO & TISSUE TECH 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,815 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:21 UTC |
Evoli LisaChief Human Resources Officer
|
Tax withholdingCommon Stock | 89 | $56.14 | $4,996.46 |
DisclosureSEC source: 0001209191-19-019765 · doc4.xml · nonDerivative · entry 7 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,259 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:21 UTC |
Evoli LisaChief Human Resources Officer
|
Tax withholdingCommon Stock | 331 | $56.14 | $18,582.34 |
DisclosureSEC source: 0001209191-19-019765 · doc4.xml · nonDerivative · entry 6 Evoli Lisa · CIK 0001661715 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,348 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:18 UTC |
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 721 | $56.14 | $40,476.94 |
DisclosureSEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 7 Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,810 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:18 UTC |
Coleman GlennCVP, CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 2,700 | $56.14 | $151,578.00 |
DisclosureSEC source: 0001209191-19-019754 · doc4.xml · nonDerivative · entry 6 Coleman Glenn · CIK 0001434369 · CVP, CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,531 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:16 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 124 | $56.14 | $6,961.36 |
DisclosureSEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 7 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,465 Read SEC document |
| March 14, 2019 Filed Mar 15, 2019 21:16 UTC |
Burhop KennethCORPVP,CHIEFSCIENTIFIC OFFICER
|
Tax withholdingCommon Stock | 461 | $56.14 | $25,880.54 |
DisclosureSEC source: 0001209191-19-019751 · doc4.xml · nonDerivative · entry 6 Burhop Kenneth · CIK 0001601582 · CORPVP,CHIEFSCIENTIFIC OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,589 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.